Biotech NewsHere’s Why Analysts Keep Raising Targets on Edgewise Therapeutics (EWTX) BioTech Health XDecember 13, 2025 At a time when treatments for severe muscle diseases were largely limited to symptom management and mutation-specific approaches,… 0 Shares 0 0 0 0 0 0 0
